Ocular change and phenothiazine therapy
Cummings, P.; Lidahl, L.L.
American Family Physician 31(5): 23
1985
ISSN/ISBN: 0002-838X PMID: 2859771 Document Number: 265441
Document emailed within 1 workday
Related Documents
Bond, W.S.; Yee, G.C. 1980: Ocular and cutaneous effects of chronic phenothiazine therapy American Journal of Hospital Pharmacy 37(1): 74-78Hesse, R.J. 1979: Anterior lens opacities in prolonged phenothiazine therapy Annals of Ophthalmology 11(8): 1212
Matsuura, M.; Miyake, Y. 1982: Effects of cervical sympathetic nerve block on the change of electroretinogram by raising intra-ocular pressure in rabbits Nippon Ganka Gakkai Zasshi 86(3): 307-314
Iwata, K.; Yaoeda, H. 1984: Influence of alignment of absolute stereo-fundus camera in progressive change on ocular fundus Nippon Ganka Gakkai Zasshi 88(12): 1464-1470
Mannion, A.F.; Junge, A.; Taimela, S.; Müntener, M.; Lorenzo, K.; Dvorak, J. 2001: Active therapy for chronic low back pain: part 3. Factors influencing self-rated disability and its change following therapy Spine 26(8): 920-929
Verin, P. 1970: Vasodilator therapy and ocular diseases Bordeaux Medical 3(10): 2509-2510
Holcová, B.; Stáhalová, D. 1975: Ocular complications in ethambutol therapy Ceskoslovenska Oftalmologie 31(4): 256-259
Dennerlein, J.A.; Lang, G.E.; Stahnke, K.; Kleihauer, E.; Lang, G.K. 1995: Ocular findings in Desferal therapy Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 92(1): 38-42
Caffery, B.E.; Josephson, J.E. 1988: Ocular side effects of isotretinoin therapy Journal of the American Optometric Association 59(3): 221-224
Agarwal, L.P.; Agarwal, H.C. 1982: Recent advances in therapy of ocular bacterial infections Indian Journal of Ophthalmology 30(4): 205-207
Conley, S.M.; Cai, X.; Naash, M.I. 2008: Nonviral ocular gene therapy: assessment and future directions Current Opinion in Molecular Therapeutics 10(5): 456-463
De Witte, E.; Coppens, A.; Missotten, L. 1979: Could PUVA therapy and solar lights provoke ocular lesions? Bulletin de la Societe Belge d'Ophtalmologie 185: 111-117
Anghel, G. 2002: Clinical and therapy features of ocular toxoplasmosis in patients with HIV-AIDS infection Oftalmologia 53(2): 93-96
Rozsíval, P.; Cigánek, L. 1978: Subjective ocular functions and objective ocular symptomatology following large doses of atropine Ceskoslovenska Oftalmologie 34(6): 409-412
Chiou, G.C.; Chen, Y.J. 1992: Improvement of ocular blood flow with dopamine antagonists on ocular-hypertensive rabbit eyes Zhongguo Yao Li Xue Bao 13(6): 481-484
Basinskiĭ, S.N.; Cherkasova, I.N. 1984: Indices of ocular hemodynamics in patients with essential ocular hypertension Vestnik Oftalmologii 4: 16-18
Debnath, S.C.; Abomelha, M.S.; Jawdat, M.; Chang, R.; Al-Khader, A.A. 1987: Ocular side effects of systemic steroid therapy in renal transplant patients Annals of Ophthalmology 19(11): 435-437
Huber, M.; Stahlmann, R. 2012: The eye as target of adverse ocular drug reactions. Focus on systemic antiinfective therapy Medizinische Monatsschrift für Pharmazeuten 35(12): 436
Teodorescu, C.; Teodorescu, I.; Raneti, C.; Dumitrica, D.M.; Stefan, C. 2008: The antitoxoplasma gondii antibodies incidence to the different ocular diseases patients cases of human ocular toxoplasmosis infections in Romania Oftalmologia 52(4): 88-94
Stefan, C.; Nenciu, A.; Malcea, C.; Tebeanu, E. 2005: Axial length of the ocular globe and hypotensive effect in glaucoma therapy with prostaglandin analogs Oftalmologia 49(4): 47-50